With a particular focus on gynecologic cancers, Bergen Cancer Imaging Research Group (BCIRG) aims to explore the role of conventional imaging and radiomic tumor profiling in clinical and preclinical cancer models in order to provide better markers with which to guide treatment and improve patient care. BCIRG is embedded within Mohn Medical Imaging and Visualization Centre and has had a long-term collaboration with Bergen Gynecologic Cancer Research Group. For more updates on BCIRG-related activities and latest news see: www.mmiv.no.
You may also read more about us on this website: https://mmiv.no/cancerimaging/
Recent advances in medical imaging methods i.e. magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and ultrasound (US) enable refined characterization of cancers from various origins. The imaging methods provide detailed information on microstructural- and functional tumor characteristics. Furthermore, the use of novel machine learning (ML) techniques on diagnostic images allows expedited automated radiomic tumor profiling, yielding information potentially relevant for prognostication and tailoring of treatment.
Group members and collaborating researchers:
Ingfrid S. Haldorsen (Professor, group leader)
Kristine E. Fasmer (Post doctor, ass. group leader)
Camilla Krakstad (Professor)
Noeska Smit (Associate Professor)
Erlend Hodneland (Senior Researcher)
Mari Kyllesø Halle (Senior Researcher)
Erling Andre Høivik (Senior Researcher)
Julie A. Dybvik (PhD student)
Njål G. Lura (PhD student)
Ankush Gulati (PhD student)
Jostein Sæterstøl (PhD student)
Agnes Jørgensen Eide (Research student)
Former group members:
Heidi Espedal (Postdoc) (2019-24)
Kari S. Wagner-Larsen (PhD dissertation 2024)
Havjin Jacob (Postdoc) (2019-21)
Hildegunn Aase (PhD dissertation 2022)
Sathiesh Kaliyugarasan (PhD dissertation 2023)
Eric Mörth (PhD dissertation 2022)
Sigmund Ytre-Hauge (PhD dissertation 2019)
Jenny Lyngstad (Research student)
Support
The group is funded by the University of Bergen, Helse-Bergen, Helse-Vest and the Bergen Research Foundation.